Oxaliplatin-induced immune mediated thrombocytopenia

Cancer Chemotherapy and Pharmacology
Muhammad S BegMalek M Safa

Abstract

Oxaliplatin is a third generation platinum compound used in patients with advanced colorectal carcinoma. Recently, the mechanism of a rare drug-induced immune thrombocytopenia in patients receiving oxaliplatin has been described. This complication is caused by oxaliplatin-dependent antibodies directed against platelet surface glycoproteins, and is unrelated to myelosuppression. In this report, we describe two patients who developed thrombocytopenia immediately soon after receiving oxaliplatin. Sensitization presumably had occurred after receiving oxaliplatin during preceding courses of multiagent chemotherapy that included oxaliplatin.

References

Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S GiacchettiF Lévi
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Jul 16, 2003·Annals of Internal Medicine·Frederick G Dold, Edith P Mitchell
Feb 3, 2004·The Oncologist·Amna IbrahimRichard Pazdur
Apr 26, 2005·Transfusion·Behrouz Mansouri TaleghaniAbdulgabar Salama
Feb 24, 2006·American Journal of Hematology·Brian R CurtisRichard H Aster

❮ Previous
Next ❯

Citations

Sep 18, 2010·Cardiovascular and Interventional Radiology·Guido PoggiGiovanni Bernardo
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Jara SánchezJ Peñalver Párraga
May 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SecondinoP Comoli
Nov 23, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C XueL Zhang
Jul 31, 2012·World Journal of Gastrointestinal Oncology·Shweta KurianYeon Ahn
Aug 11, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·W CeelenP Pattyn
Feb 14, 2012·The Journal of Pain : Official Journal of the American Pain Society·Lorenzo Di Cesare MannelliCarla Ghelardini
Oct 14, 2009·Clinical Colorectal Cancer·Edward JamesMuhammad Wasif Saif
Mar 10, 2010·Transfusion·Rita Fontão-WendelSilvano Wendel
Jul 28, 2016·Journal of Cancer Research and Therapeutics·Gokmen Umut ErdemNurullah Zengin
Feb 7, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Nicholas P ForcelloDriola Brahaj
Aug 12, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jessica M Mason, Gareth Jg Rees
Nov 15, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maarten J Ten BergToine C G Egberts
Mar 2, 2013·Internal Medicine·Kei SuzukiNaoyuki Katayama
Apr 3, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Shinji KobuchiYukako Ito
Nov 23, 2017·Cancer Chemotherapy and Pharmacology·Yukako ItoYosuke Katsuyama
Oct 6, 2020·Clinical Colorectal Cancer·Anthony StackCrystal S Denlinger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved